Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Are you comfortable using low molecular weight heparin as an alternative to unfractionated heparin for ESKD patients on nocturnal home hemodialysis?
Related Questions
Would you consider not returning the blood from the dialysis circuit as a strategy for managing polycythemia in a patient with ESKD on hemodialysis who has a hemoglobin level greater than 16 g/dL?
Do you use the same hemoglobin target as an ESKD patient for an outpatient with AKI-D who has been receiving dialysis for more than 30 days and is prescribed an ESA?
How long do you recommend waiting before repeating a serum electrolyte panel after the conclusion of an intermittent hemodialysis session to ensure accurate results are obtained?
Do you dose ESAs via an intravenous or subcutaneous route for hospitalized patients with ESKD and anemia?
How do you approach selecting a dialysis modality for a patient with advanced CKD who is interested in home therapy but has a history of medication non-adherence and poor attendance at clinic appointments?
Would you recommend pre-dialysis exercise for an ESKD patient as a means of cardioprotection?
What is your preferred blood flow rate for a patient with ESKD who has an AVF but is only undergoing an ultrafiltration session?
How would you approach a patient with ESKD on HD who denies a history of abdominal hernias but lifts heavy objects daily as part of work requirements and is desiring to transition to PD?
What is your approach to intensifying the hemodialysis prescription for patients found to have dialysis-related amyloidosis?
How do you modify your peritonitis prevention strategy for a patient starting peritoneal dialysis who has a history of recurrent staphylococcal skin infections?
